ANEB icon

Anebulo Pharmaceuticals

15 hedge funds and large institutions have $37.3M invested in Anebulo Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
2
Increased
6
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
2L
1
22NW LP
Washington
$26M +$17M +10,101,010 +188%
NCM
2
Nantahala Capital Management
Connecticut
$5.1M +$4.24M +2,525,252 +494%
MP
3
Mangrove Partners
Connecticut
$3.64M +$3.64M +2,525,252 New
LA
4
LVW Advisors
New York
$1.06M -$14.3K -8,523 -1%
Morgan Stanley
5
Morgan Stanley
New York
$706K +$34.9K +20,775 +5%
IC
6
Ikarian Capital
Texas
$265K -$239 -142 -0.1%
Vanguard Group
7
Vanguard Group
Pennsylvania
$259K
Geode Capital Management
8
Geode Capital Management
Massachusetts
$153K +$5.97K +3,551 +4%
Luther King Capital Management (LKCM)
9
Luther King Capital Management (LKCM)
Texas
$100K +$100K +59,662 New
BFM
10
Boothbay Fund Management
New York
$31.6K -$239 -142 -0.7%
BlackRock
11
BlackRock
New York
$6.6K +$40 +24 +0.6%
TRCT
12
Tower Research Capital (TRC)
New York
$5.59K +$1.06K +632 +23%
Bank of America
13
Bank of America
North Carolina
$128
UBS Group
14
UBS Group
Switzerland
$42 -$1.24K -738 -97%
JPMorgan Chase & Co
15
JPMorgan Chase & Co
New York
$15